BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 196 filers reported holding BLUEBIRD BIO INC in Q4 2015. The put-call ratio across all filers is 1.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $32,049,000 | +42.0% | 203,705 | -10.5% | 0.04% | +21.9% |
Q4 2018 | $22,570,000 | -63.1% | 227,522 | -45.7% | 0.03% | -13.5% |
Q3 2018 | $61,152,000 | +55.9% | 418,844 | +67.6% | 0.04% | -24.5% |
Q2 2018 | $39,225,000 | -19.8% | 249,921 | -12.8% | 0.05% | -22.2% |
Q1 2018 | $48,920,000 | -4.8% | 286,503 | -0.7% | 0.06% | -4.5% |
Q4 2017 | $51,401,000 | +36.2% | 288,607 | +5.0% | 0.07% | +29.4% |
Q3 2017 | $37,736,000 | +44.0% | 274,746 | +10.1% | 0.05% | +37.8% |
Q2 2017 | $26,207,000 | +145.9% | 249,475 | +112.8% | 0.04% | +131.2% |
Q1 2017 | $10,659,000 | +47.4% | 117,262 | +0.0% | 0.02% | +45.5% |
Q4 2016 | $7,231,000 | -29.7% | 117,204 | -22.7% | 0.01% | -35.3% |
Q3 2016 | $10,279,000 | +215.1% | 151,646 | +101.2% | 0.02% | +183.3% |
Q2 2016 | $3,262,000 | +66.7% | 75,356 | +63.6% | 0.01% | +50.0% |
Q1 2016 | $1,957,000 | -30.2% | 46,048 | +5.5% | 0.00% | -20.0% |
Q4 2015 | $2,802,000 | -21.9% | 43,632 | +4.0% | 0.01% | -28.6% |
Q3 2015 | $3,590,000 | -77.1% | 41,969 | -54.9% | 0.01% | -75.9% |
Q2 2015 | $15,665,000 | +20.4% | 93,037 | -13.6% | 0.03% | +20.8% |
Q1 2015 | $13,011,000 | +262.1% | 107,734 | +175.0% | 0.02% | +242.9% |
Q4 2014 | $3,593,000 | +181.6% | 39,175 | +10.2% | 0.01% | +133.3% |
Q3 2014 | $1,276,000 | +23.2% | 35,553 | +32.3% | 0.00% | +50.0% |
Q2 2014 | $1,036,000 | +384.1% | 26,870 | +184.9% | 0.00% | – |
Q1 2014 | $214,000 | +8.1% | 9,430 | 0.0% | 0.00% | – |
Q4 2013 | $198,000 | +14.5% | 9,430 | +46.7% | 0.00% | – |
Q3 2013 | $173,000 | – | 6,430 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 4,282,827 | $13,019,794 | 1.84% |
Birchview Capital, LP | 455,200 | $1,383,808 | 1.18% |
PFM Health Sciences, LP | 6,040,934 | $18,364,439 | 0.86% |
Lion Point Capital, LP | 531,256 | $1,615,018 | 0.72% |
Endurant Capital Management LP | 251,785 | $765,426 | 0.69% |
Bleichroeder LP | 900,000 | $2,736,000 | 0.67% |
Connacht Asset Management LP | 31,634 | $96,167 | 0.57% |
Granahan Investment Management | 5,137,778 | $15,618,845 | 0.56% |
Frazier Life Sciences Management, L.P. | 1,709,907 | $5,198,117 | 0.34% |
Contrarius Investment Management Ltd | 1,308,002 | $3,976 | 0.22% |